Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$36.06 - $117.21 $8.73 Million - $28.4 Million
242,000 Added 72.85%
574,200 $63.2 Million
Q3 2022

Nov 14, 2022

BUY
$28.17 - $59.01 $6.5 Million - $13.6 Million
230,600 Added 226.97%
332,200 $19.6 Million
Q2 2022

Aug 15, 2022

BUY
$22.39 - $38.94 $2.27 Million - $3.96 Million
101,600 New
101,600 $2.87 Million

Others Institutions Holding RXDX

About Prometheus Biosciences, Inc.


  • Ticker RXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,904,100
  • Description
  • Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...
More about RXDX
Track This Portfolio

Track Sio Capital Management, LLC Portfolio

Follow Sio Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sio Capital Management, LLC with notifications on news.